rs1292467126 (chr2:g.226447080 A>G) in exon 4 of neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 (NYAP2) was the most commonly associated variant, with chemosensitivity to four anti-cancer drugs: CPM (P = 3.98 × 10−3, rs = -0.361; Table 4), ADR (P = 4.95 × 10−3, rs = -0.355; Table 3), VCR (P = 6.22 × 10−3, rs = -0.347; Table 8), and ACNU (P = 9.33 × 10−3, rs = -0.330; Table 2). Here, NYAP2 is linked to cancer.